MedTrace Logo

Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery

NCT00651573 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 722

Last updated 2019-06-14

Study results available
· View outcomes & findings →

Summary

The primary purpose of this study is to determine the best blood level to begin transfusing red blood cells in individuals undergoing cardiac surgery.

The secondary aim is to determine the impact of red cell transfusion on health-related quality of life following surgery.

Conditions

Interventions

PROCEDURE

Blood transfusion at hematocrit value less than 24%

transfusion

PROCEDURE

Blood transfusion at hematocrit value less than 28%

transfusion

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Daniel I Sessler, MD · The Cleveland Clinic

  • Daniel I Sessler, MD · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2014-08-31
Completion
2019-01-03

Countries

  • United States
  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00651573 on ClinicalTrials.gov